JP2023109996A5 - - Google Patents

Download PDF

Info

Publication number
JP2023109996A5
JP2023109996A5 JP2023089684A JP2023089684A JP2023109996A5 JP 2023109996 A5 JP2023109996 A5 JP 2023109996A5 JP 2023089684 A JP2023089684 A JP 2023089684A JP 2023089684 A JP2023089684 A JP 2023089684A JP 2023109996 A5 JP2023109996 A5 JP 2023109996A5
Authority
JP
Japan
Prior art keywords
vaccine
functional
live attenuated
deleted
bordetella strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023089684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023109996A (ja
JP7812352B2 (ja
Filing date
Publication date
Priority claimed from JP2020520777A external-priority patent/JP7335874B2/ja
Application filed filed Critical
Publication of JP2023109996A publication Critical patent/JP2023109996A/ja
Publication of JP2023109996A5 publication Critical patent/JP2023109996A5/ja
Application granted granted Critical
Publication of JP7812352B2 publication Critical patent/JP7812352B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023089684A 2017-10-18 2023-05-31 血清型3線毛を発現するボルデテラ(bordetella)菌株 Active JP7812352B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762574068P 2017-10-18 2017-10-18
US62/574,068 2017-10-18
JP2020520777A JP7335874B2 (ja) 2017-10-18 2018-10-18 血清型3線毛を発現するボルデテラ(bordetella)菌株
PCT/EP2018/078522 WO2019077028A1 (en) 2017-10-18 2018-10-18 BORDETELLA STRAINS EXPRESSING SERO-TYPE FIMBRIAE 3

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020520777A Division JP7335874B2 (ja) 2017-10-18 2018-10-18 血清型3線毛を発現するボルデテラ(bordetella)菌株

Publications (3)

Publication Number Publication Date
JP2023109996A JP2023109996A (ja) 2023-08-08
JP2023109996A5 true JP2023109996A5 (https=) 2023-11-28
JP7812352B2 JP7812352B2 (ja) 2026-02-09

Family

ID=64664226

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020520777A Active JP7335874B2 (ja) 2017-10-18 2018-10-18 血清型3線毛を発現するボルデテラ(bordetella)菌株
JP2023089684A Active JP7812352B2 (ja) 2017-10-18 2023-05-31 血清型3線毛を発現するボルデテラ(bordetella)菌株

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020520777A Active JP7335874B2 (ja) 2017-10-18 2018-10-18 血清型3線毛を発現するボルデテラ(bordetella)菌株

Country Status (8)

Country Link
US (2) US11446372B2 (https=)
EP (1) EP3697439A1 (https=)
JP (2) JP7335874B2 (https=)
CN (2) CN118979003A (https=)
AU (1) AU2018353409B2 (https=)
CA (1) CA3077428A1 (https=)
SG (1) SG11202003333WA (https=)
WO (1) WO2019077028A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119804B2 (en) 2006-03-10 2015-09-01 Institut Pasteur De Lille Live attenuated bordetella strains as a single dose vaccine against whooping cough
SG175803A1 (en) 2009-04-28 2011-12-29 Pasteur Institut Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
SG11202003333WA (en) * 2017-10-18 2020-05-28 Pasteur Institut Bordetella strains expressing serotype 3 fimbriae
EP4247397A4 (en) 2020-11-17 2024-11-06 Iliad Biotechnologies, LLC TREATMENT AND PREVENTION OF NEUROPATHOLOGY ASSOCIATED WITH NEURODEGENERATIVE DISEASES

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US6713072B1 (en) 1987-11-02 2004-03-30 Chiron S.R.L. Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
IT1236971B (it) * 1989-11-03 1993-05-07 Eniricerche Spa Regione promotore dei geni codificanti le subunita' piliniche fim2, fm3 e fimx di bordetella pertussis e loro impiego per l'espressione di geni che codificano una proteina di interesse.
GB9115332D0 (en) 1991-07-16 1991-08-28 Connaught Lab Manipulation of gene copy number in bordetella
FR2718750B1 (fr) 1994-04-19 1996-06-14 Pasteur Institut Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants.
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
FR2840319B1 (fr) 2002-05-30 2004-08-20 Pasteur Institut Souches de bordetella rendues deficientes par attenuation genetique
EP1617805A4 (en) 2003-04-11 2012-07-04 Medimmune Llc METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS
GB0402131D0 (en) * 2004-01-30 2004-03-03 Isis Innovation Delivery method
US9119804B2 (en) * 2006-03-10 2015-09-01 Institut Pasteur De Lille Live attenuated bordetella strains as a single dose vaccine against whooping cough
CA2669485C (en) 2006-11-15 2017-01-03 Folia Biotech Inc. Papaya mosaic virus-based vaccines for influenza
EP2134359A4 (en) 2007-02-23 2010-06-16 Penn State Res Found USE OF A NONVIRULENT BORDETELLA MUTANT AS LIVING VACCINE VECTOR
CN100537767C (zh) * 2007-04-29 2009-09-09 中国药品生物制品检定所 百日咳疫苗保护性抗原的重组表达及其应用
WO2008156753A1 (en) 2007-06-18 2008-12-24 Hemispherx Biopharma Early intervention of viral infections with immune activators
SG175803A1 (en) 2009-04-28 2011-12-29 Pasteur Institut Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
DK2442826T3 (en) 2009-06-15 2015-09-21 Univ Singapore Influenza vaccine, composition and methods of using
DK2773371T3 (da) * 2011-11-02 2020-03-09 Nat Univ Singapore Virkning af en svækket bordetella-stamme mod allergisk sygdom
AU2013301312A1 (en) * 2012-08-06 2015-03-19 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against RSV and B. pertussis
EP2722338A1 (en) * 2012-10-17 2014-04-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel recombinant Bordetella strains
US9655959B2 (en) * 2014-10-01 2017-05-23 National University Of Singapore Adenylate cyclase deficient bordetella strains
EP4541809A3 (en) 2016-03-29 2025-06-25 Institut Pasteur de Lille Mutant bordetella strains and methods of use
US10799573B2 (en) * 2016-03-30 2020-10-13 Regents Of The University Of Minnesota Pertussis vaccines and methods of making and using
US20200171169A1 (en) * 2017-05-15 2020-06-04 Vanderbilt University LONG-CIRCULATING ZWITTERIONIC POLYPLEXES FOR siRNA DELIVERY
CN111032078A (zh) * 2017-07-18 2020-04-17 血清研究所印度私人有限公司 具有改善的稳定性、增强的免疫原性和降低的反应原性的免疫原性组合物及其制备方法
SG11202003333WA (en) * 2017-10-18 2020-05-28 Pasteur Institut Bordetella strains expressing serotype 3 fimbriae
US12036405B2 (en) * 2018-03-23 2024-07-16 The Board Of Regents Of The University Of Oklahoma System and method of electric-induced acoustic tomography for electrotherapy monitoring
WO2020049133A1 (en) 2018-09-05 2020-03-12 National University Of Singapore Adenylate cyclase catalytic domain deficient bordetella strains

Similar Documents

Publication Publication Date Title
JP2023109996A5 (https=)
JP2019517828A5 (https=)
JP2024170583A5 (https=)
JP2023535744A5 (https=)
JP7812352B2 (ja) 血清型3線毛を発現するボルデテラ(bordetella)菌株
AU2017242541B2 (en) Mutant bordetella strains and methods for use
EP1305042B1 (en) Compositions comprising non-typable Haemophilus influenzae (NTHI) and probiotic bacteria for the treatment of mucosal infections caused by NTHI
JP2023535163A5 (https=)
JP2012527218A5 (https=)
JP2021500325A5 (https=)
JP2025148449A5 (https=)
JP2023520929A5 (https=)
JP2005533116A5 (https=)
Tulp et al. An Editorial overview and Perspective: Can the attenuated Omicron variant of Covid-19 virus resolve the pandemic in 2022
Okerman et al. Protective effects of inactivated pasteurella vaccines in specific pathogen free rabbits
JP6867623B2 (ja) 百日咳モデル動物およびその作製方法、ならびに百日咳モデル動物を用いた方法
CN110841069A (zh) 一种含有沙利度胺与抗真菌药物的药物组合物及应用
RU2339389C2 (ru) Способ профилактики назофарингиального носительства патогенной микрофлоры
HK40115864A (zh) 表达血清3型菌毛的鲍特菌属菌株
KR20250038747A (ko) 만성 폐쇄성 폐질환의 치료를 위한 보르데텔라 균주의 용도
Föhse Vaccine-induced trained immunity: effects on COVID-19 and beyond
Thomsen THE BURNS UNIT IN COPENHAGEN: 10. Antibiotic Sensitivity of Staphylococcus aureus Isolated from Burns
YAOI et al. RESULT OF ACTIVE IMMUNIZATION AGAINST PERTUSSIS BY COMBINED H. PERTUSSIS VACCINE AND VACCINIA VIRUS, PERFORMED AT VILLAGES IN KANAGAWA PREFECTURE
JP2024527138A5 (https=)
HK40026630B (zh) 表达血清3型菌毛的鲍特菌属菌株